Steven P. Coen is See remarks at Ginkgo Bioworks Holdings, Inc. (DNA). They have made 25 open-market trades across 1 company since 2024, most recently 2026-10-05.
CIK 0001977441
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 25 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DNA | 49,448 | $508K |
Shares reported on the most recent Form 4, priced at the 2026-10-07 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DNA | SELL · 10b5-1 | 2026-10-05 | 2026-10-07 | $15.00 | $36K | — | — | — |
| DNA | SELL | 2026-08-24 | 2026-08-25 | $6.98 | $2K | -5.8% | +39.1% | — |
| DNA | SELL | 2026-07-17 | 2026-07-20 | $7.90 | $6K | +5.9% | +1.0% | — |
| DNA | SELL | 2026-05-22 | 2026-05-26 | $8.33 | $3K | -6.3% | +9.4% | -22.5% |
| DNA | SELL | 2026-04-17 | 2026-04-20 | $7.95 | $3K | +5.5% | -3.4% | -5.7% |
| DNA | SELL | 2026-04-13 | 2026-04-14 | $6.41 | $213K | +1.2% | +0.8% | +16.5% |
| DNA | SELL | 2026-03-16 | 2026-03-18 | $6.74 | $10K | -13.7% | +26.5% | +29.6% |
| DNA | SELL | 2026-01-20 | 2026-01-22 | $8.92 | $9K | -18.0% | -17.4% | -21.3% |
| DNA | SELL | 2025-12-15 | 2025-12-16 | $8.89 | $7K | -1.1% | +16.0% | -18.3% |
| DNA | SELL | 2025-10-17 | 2025-10-21 | $13.65 | $18K | +1.6% | -38.8% | -29.3% |
| DNA | SELL | 2025-10-01 | 2025-10-03 | $15.00 | $84K | -2.4% | -21.1% | -46.4% |
| DNA | SELL | 2025-08-22 | 2025-08-26 | $12.40 | $4K | -11.1% | -10.6% | -31.6% |
| DNA | SELL | 2025-07-17 | 2025-07-21 | $9.84 | $11K | +15.9% | +2.2% | +20.2% |
| DNA | SELL | 2025-05-21 | 2025-05-22 | $7.59 | $3K | +12.0% | +26.4% | +71.7% |
| DNA | SELL | 2025-04-21 | 2025-04-23 | $7.28 | $7K | -9.9% | -9.0% | +73.8% |
| DNA | SELL | 2025-03-04 | 2025-03-06 | $7.73 | $3K | -6.1% | -17.3% | -2.5% |
| DNA | SELL | 2025-02-04 | 2025-02-06 | $13.44 | $5K | -8.8% | -50.0% | -46.8% |
| DNA | SELL | 2025-01-06 | 2025-01-08 | $11.72 | $4K | +19.7% | +32.2% | -46.6% |
| DNA | SELL | 2024-12-04 | 2024-12-05 | $9.64 | $3K | -1.9% | +18.9% | -15.7% |
| DNA | SELL | 2024-11-04 | 2024-11-06 | $7.58 | $3K | -24.6% | +39.0% | +70.3% |
| DNA | SELL | 2024-10-04 | 2024-10-08 | $8.35 | $3K | +7.4% | +1.3% | +40.9% |
| DNA | SELL | 2024-09-12 | 2024-09-16 | $6.17 | $2K | +20.9% | +29.8% | +48.0% |
| DNA | SELL | 2024-08-02 | 2024-08-06 | $0.29 | $5K | -23.5% | -47.0% | -34.1% |
| DNA | SELL | 2024-07-02 | 2024-07-05 | $0.33 | $4K | -0.4% | -8.9% | -39.1% |
| DNA | SELL | 2024-06-03 | 2024-06-05 | $0.55 | $7K | -17.9% | -36.1% | -70.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.